September 27, 2022
Optimal dosing, modes of administration and the most effective forms of adjunctive psychotherapeutic support should be examined further. The Food and Drug Administration (FDA) recently approved the use of intranasal esketamine for the treatment of TRD (40,41). However, it is Read more…

Recent Comments